Literature DB >> 29697417

Chinese herbal medicines in the prevention and treatment of chemotherapy-induced nausea and vomiting.

Chang Lv1, Chengjin Shi1, Lifen Li1, Xuesen Wen1, Cory J Xian2.   

Abstract

PURPOSE OF REVIEW: Chemotherapy-induced nausea and vomiting (CINV) critically impact on cancer patients' quality of life, causing various complications, and increasing the risk of chemotherapeutic failure. Current treatments addressing CINV are reasonably costly and have many side effects. Chinese herbal medicines (CHMs) have been widely used in treating CINV in China. Clinical trials and modern experimental studies on CINV using CHMs are reviewed for clues that may help us to better prevent and treat CINV with CHMs, and develop safe and effective treatments. RECENT
FINDINGS: Since 1985, 92 clinical trials on CINV were identified, which comprised of 3778 patients with different cancer types, chemotherapy regimens, prescriptions, treatment durations, and combinations with Western medicines. The most frequently used herbs are Pinellia Rhizoma, Glycyrrhizae Radix et Rhizoma, Poria, and Atractylodis Macrocephalae Rhizoma, aiming to regulate the flow of Qi and remove phlegm and dampness residing in the stomach and spleen. Although all of the reported trials are randomized open trials, the curative effects range from 55.81 to 100%.
SUMMARY: CHMs seem effective in the prevention and treatment of CINV based on the clinical trials and some animal experiments, although the scientific validity of many clinical studies remain to be confirmed as many of them were inadequately designed. Further well designed clinical trials and more preclinical studies with reliable markers are required to confirm the usefulness of CHMs as complementary medicines for treating CINV and to use CHMs as rational prescriptions rather than based only on empirical knowledge.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29697417     DOI: 10.1097/SPC.0000000000000348

Source DB:  PubMed          Journal:  Curr Opin Support Palliat Care        ISSN: 1751-4258            Impact factor:   2.302


  8 in total

1.  Physician Preferences and Shared-Decision Making for the Traditional Chinese Medicine Treatment of Lung Cancer: A Discrete-Choice Experiment Study in China.

Authors:  Juntao Yan; Yan Wei; Yue Teng; Shimeng Liu; Fuming Li; Shiyi Bao; Yanfeng Ren; Yingyao Chen
Journal:  Patient Prefer Adherence       Date:  2022-06-17       Impact factor: 2.314

2.  In vitro and in vivo effects of traditional Chinese medicine formula T33 in human breast cancer cells.

Authors:  Yu-Te Liu; Chao-Hsiang Hsiao; Bor-Show Tzang; Tsai-Ching Hsu
Journal:  BMC Complement Altern Med       Date:  2019-08-13       Impact factor: 3.659

Review 3.  Potential Therapeutic Effect of Traditional Chinese Medicine on Coronavirus Disease 2019: A Review.

Authors:  Qin Qiu; Yuge Huang; Xiaohua Liu; Fangfang Huang; Xiaoling Li; Liao Cui; Hui Luo; Lianxiang Luo
Journal:  Front Pharmacol       Date:  2020-11-09       Impact factor: 5.810

4.  Gastroprotective mechanism of modified lvdou gancao decoction on ethanol-induced gastric lesions in mice: Involvement of Nrf-2/HO-1/NF-κB signaling pathway.

Authors:  Lei Xie; Minyi Luo; Junlin Li; Wenguan Huang; Guangjun Tian; Xiuyun Chen; Ying Ai; Yan Zhang; Haolan He
Journal:  Front Pharmacol       Date:  2022-09-01       Impact factor: 5.988

5.  Traditional Chinese medicine formula T33 inhibits the proliferation of human colorectal cancer cells by inducing autophagy.

Authors:  Yu-Te Liu; Bor-Show Tzang; JiaLe Yow; Yi-Hsuan Chiang; Chih-Yang Huang; Tsai-Ching Hsu
Journal:  Environ Toxicol       Date:  2022-01-07       Impact factor: 4.109

6.  External Application of Traditional Chinese Medicine in the Prevention and Treatment of Nausea and Vomiting Caused by Chemotherapy of Non-Small-Cell Lung Cancer: A RCT Study.

Authors:  Song-Jing Zhou; Lin Tang; Yong-Jun Fu; Chang-Qing Yang; Jia Shi
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-04       Impact factor: 2.650

7.  Aidi Injection, a Traditional Chinese Medicine Injection, Could Be Used as an Adjuvant Drug to Improve Quality of Life of Cancer Patients Receiving Chemotherapy: A Propensity Score Matching Analysis.

Authors:  Gang Xie; Zhihua Cui; Kai Peng; Xiehai Zhou; Quan Xia; Dujuan Xu
Journal:  Integr Cancer Ther       Date:  2018-11-27       Impact factor: 3.279

8.  Identification of potential targets of triptolide in regulating the tumor microenvironment of stomach adenocarcinoma patients using bioinformatics.

Authors:  Hairong Qiu; Xiaobo Zhang; Han Yu; Rui Gao; Jianglong Shi; Tao Shen
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.